{"id":{"repo_id":"ajou","oai_identifier":"oai:repository.ajou.ac.kr:201003/2246"},"canonical_url":"https://search.dev.ndltd.org/etd/ajou/oai:repository.ajou.ac.kr:201003/2246","repository":{"repo_id":"ajou","name":"Ajou University","base_url":"http://repository.ajou.ac.kr/oai/request"},"display":{"title":"Identification of Regulatory DNA Region and Transcription Factors Important for TIM-3 Transcription","abstract":"TIM-3는 T 세포 immunoglobulin- and mucin-domain-containing molecules (TIMs) family의 하나로서 보조 T 세포 1형에서 특이적으로 발현하는 분자로 발견되었다. 이 분자는 비만세포에서도 발현이 되며 TGF-β에 의해 발현이 증가한다고 알려졌으나 분자생물학적인 발현기작에 대해서는 연구되지 않았다. 본 연구에서는 TIM-3의 분자생물학적인 발현조절기작을 밝히기 위해 TIM-3 upstream DNA와 intron 1과 2를 각각 포함하는 luciferase reporter vector를 제작한 후 사람 비만세포 주에서 luciferase 활성을 측정하였다. 그 결과 TIM-3 upstream -349/+142 부분이 전사활성에 있어서 중요한 역할을 하며 TGF-β 처리에 의한 TIM-3 발현 증가에서도 중요하게 작용함을 보였다. 또한 TGF-β 신호전달에 중요한 smad 2와 smad 4과발현 시스템을 이용하여 TGF-β에 의한 TIM-3 발현증가에 smad 2와 smad 4가 관여함을 제시하였다. 본 연구의 결과는 TIM-3 전사조절에 중요한 upatream DNA region을 밝힘으로써 TIM-3 발현 조절 기작을 이해하는데 중요한 초석이 된다.","abstract_html":"TIM-3는 T 세포 immunoglobulin- and mucin-domain-containing molecules (TIMs) family의 하나로서 보조 T 세포 1형에서 특이적으로 발현하는 분자로 발견되었다. 이 분자는 비만세포에서도 발현이 되며 TGF-β에 의해 발현이 증가한다고 알려졌으나 분자생물학적인 발현기작에 대해서는 연구되지 않았다. 본 연구에서는 TIM-3의 분자생물학적인 발현조절기작을 밝히기 위해 TIM-3 upstream DNA와 intron 1과 2를 각각 포함하는 luciferase reporter vector를 제작한 후 사람 비만세포 주에서 luciferase 활성을 측정하였다. 그 결과 TIM-3 upstream -349/+142 부분이 전사활성에 있어서 중요한 역할을 하며 TGF-β 처리에 의한 TIM-3 발현 증가에서도 중요하게 작용함을 보였다. 또한 TGF-β 신호전달에 중요한 smad 2와 smad 4과발현 시스템을 이용하여 TGF-β에 의한 TIM-3 발현증가에 smad 2와 smad 4가 관여함을 제시하였다. 본 연구의 결과는 TIM-3 전사조절에 중요한 upatream DNA region을 밝힘으로써 TIM-3 발현 조절 기작을 이해하는데 중요한 초석이 된다.","abstract_has_math":false,"creators":["김, 정식"],"institution":null,"degree_name":null,"degree_level":null,"degree_discipline":null,"degree_department":null,"school":null,"contributors":["박, 선","대학원 의생명과학과","200724137"],"advisors":[],"committee_chairs":[],"committee_members":[],"year":2011,"date_issued":"2011-04-13T04:55:03Z","date_published":"2011-04-13T04:55:03Z","updated_at":"2026-07-24T00:51:31Z","subjects":["T cell immunoglobulin- and mucin domain-3(TIM-3)","전사","프로모터"],"languages":["ko"],"rights":[],"rights_urls":[],"identifier_entries":[{"key":"dc:identifier","label":"Identifier","values":["http://dcoll.ajou.ac.kr:9080/dcollection/jsp/common/DcLoOrgPer.jsp?sItemId=000000009556","000000009556"],"render_values":[{"text":"http://dcoll.ajou.ac.kr:9080/dcollection/jsp/common/DcLoOrgPer.jsp?sItemId=000000009556","href":"http://dcoll.ajou.ac.kr:9080/dcollection/jsp/common/DcLoOrgPer.jsp?sItemId=000000009556","code":true},{"text":"000000009556","href":null,"code":true}]}]},"links":{"outbound_url":"http://repository.ajou.ac.kr/handle/201003/2246","outbound_label":"Repository record","outbound_source":"dc:identifier"},"metadata_groups":[{"id":"people","label":"People","entries":[{"key":"dc:contributor","label":"Contributor","values":["박, 선","대학원 의생명과학과","200724137","김, 정식"]},{"key":"dc:creator","label":"Author","values":["김, 정식"]}]},{"id":"academic_context","label":"Academic Context","entries":[{"key":"dc:date","label":"Dc Date","values":["2011-04-13T04:55:03Z","2009"]},{"key":"dc:type","label":"Dc Type","values":["Thesis","Theses"]}]},{"id":"subjects_keywords","label":"Subjects and Keywords","entries":[{"key":"dc:subject","label":"Dc Subject","values":["T cell immunoglobulin- and mucin domain-3(TIM-3)","전사","프로모터"]}]},{"id":"language_rights","label":"Language and Rights","entries":[{"key":"dc:language","label":"Dc Language","values":["ko"]}]},{"id":"identifiers","label":"Identifiers","entries":[{"key":"dc:identifier","label":"Identifier","values":["http://repository.ajou.ac.kr/handle/201003/2246","http://dcoll.ajou.ac.kr:9080/dcollection/jsp/common/DcLoOrgPer.jsp?sItemId=000000009556","000000009556"]}]},{"id":"additional","label":"Additional Metadata","entries":[{"key":"dc:description","label":"Description","values":["TIM-3는 T 세포 immunoglobulin- and mucin-domain-containing molecules (TIMs) family의 하나로서 보조 T 세포 1형에서 특이적으로 발현하는 분자로 발견되었다. 이 분자는 비만세포에서도 발현이 되며 TGF-β에 의해 발현이 증가한다고 알려졌으나 분자생물학적인 발현기작에 대해서는 연구되지 않았다. 본 연구에서는 TIM-3의 분자생물학적인 발현조절기작을 밝히기 위해 TIM-3 upstream DNA와 intron 1과 2를 각각 포함하는 luciferase reporter vector를 제작한 후 사람 비만세포 주에서 luciferase 활성을 측정하였다. 그 결과 TIM-3 upstream -349/+142 부분이 전사활성에 있어서 중요한 역할을 하며 TGF-β 처리에 의한 TIM-3 발현 증가에서도 중요하게 작용함을 보였다. 또한 TGF-β 신호전달에 중요한 smad 2와 smad 4과발현 시스템을 이용하여 TGF-β에 의한 TIM-3 발현증가에 smad 2와 smad 4가 관여함을 제시하였다. 본 연구의 결과는 TIM-3 전사조절에 중요한 upatream DNA region을 밝힘으로써 TIM-3 발현 조절 기작을 이해하는데 중요한 초석이 된다.","\"차 례 국문요약 &#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729; i 차례 &#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729; ii 그림 차례 &#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729; iii 표 차례 &#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729; vi I. 서론 &#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729; 1 II. 재료 및 방법 &#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729; 5 A. TIM-3 upstream DNA와 intron 을 삽입한 luciferase reporter plasmid 제작 &#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729; 5 B. 세포배양과 plasmid의 세포이입 &#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729; 6 C. Luciferase reporter assay &#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729; 8 D. RNA 추출과 Real-time PCR &#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729; 8 E. Site directed mutagenesis &#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729; 11 F. 통계처리 &#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729; 11 III. 결과 &#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729; 13 A. TGF-β 자극에 의한 TIM-3 mRNA 발현 증가 &#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729; 13 B. 인간과 생쥐의 TIM-3 regulatory DNA의 상동성 분석 &#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729; 13 C. HMC-1의 TIM-3 regulatory DNA 염기서열 분석 &#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729; 20 D. TIM-3 발현 조절 DNA의 luciferase reporter vector 생산 &#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729; 20 E. Basal level의 TIM-3 전사활성에 중요한 DNA region 분석 &#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729; 25 F. TGF-β 자극에 따른 TIM-3 전사증가에 관여하는 DNA region분석 &#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729; 30 G. Smad 분자 과발현이 TIM-3 enhancer/promoter 활성에 미치는 영향 &#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729; 30 IV. 고찰 &#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729; 33 V. 결론 &#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729; 37 참고문헌 &#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729; 38 ABSTRACT &#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729; 45 그 림 차 례 Fig. 1. HMC-1 세포와 HEK 293 세포의 TGF-β 자극에 의한 TIM-3 mRNA 양의 변화 &#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729; 15 Fig. 2. 사람 TIM-3와 생쥐 tim-3의 upstream DNA와 intron 염기서열의 상동성 분석 &#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729; 17 Fig. 3. 인간 혈액/정자에서 보고된 TIM-3 유전자 염기서열과 HMC-1에서 분리한 TIM-3 upstream DNA의 염기서열 비교 &#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729; 22 Fig. 4. TIM-3의 upstream DNA와 intron 1과 2의 luciferase reporter vector 제작 &#8729;&#8729;&#8729; 23 Fig. 5. TIM-3 조절 유전자에 의한 luciferase 활성 분석 &#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729; 27 Fig. 6. TGF-β 자극이 TIM-3 upstream DNA에 의한 luciferase 활성에 미치는 영향 &#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729; 31 Fig. 7. TIM-3 upstream DNA에 의한 luciferase 활성에 smad 과발현이 미치는 영향 &#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729; 32 표 차 례 Table. 1. Primers for amplification of TIM-3 upstream DNA and introns &#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729; 7 Table. 2. Primers and probes for real-time PCR &#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729; 9 Table 3. Primers for site directed mutagenesis &#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729; 12 \"","Master"]},{"key":"dc:title","label":"Title","values":["Identification of Regulatory DNA Region and Transcription Factors Important for TIM-3 Transcription","TIM-3 발현 조절에 중요한 DNA region과 이에 관여하는 전사인자 분석"]}]}],"canonical_facts":{"dc:contributor":["박, 선","대학원 의생명과학과","200724137","김, 정식"],"dc:creator":["김, 정식"],"dc:date":["2011-04-13T04:55:03Z","2009"],"dc:description":["TIM-3는 T 세포 immunoglobulin- and mucin-domain-containing molecules (TIMs) family의 하나로서 보조 T 세포 1형에서 특이적으로 발현하는 분자로 발견되었다. 이 분자는 비만세포에서도 발현이 되며 TGF-β에 의해 발현이 증가한다고 알려졌으나 분자생물학적인 발현기작에 대해서는 연구되지 않았다. 본 연구에서는 TIM-3의 분자생물학적인 발현조절기작을 밝히기 위해 TIM-3 upstream DNA와 intron 1과 2를 각각 포함하는 luciferase reporter vector를 제작한 후 사람 비만세포 주에서 luciferase 활성을 측정하였다. 그 결과 TIM-3 upstream -349/+142 부분이 전사활성에 있어서 중요한 역할을 하며 TGF-β 처리에 의한 TIM-3 발현 증가에서도 중요하게 작용함을 보였다. 또한 TGF-β 신호전달에 중요한 smad 2와 smad 4과발현 시스템을 이용하여 TGF-β에 의한 TIM-3 발현증가에 smad 2와 smad 4가 관여함을 제시하였다. 본 연구의 결과는 TIM-3 전사조절에 중요한 upatream DNA region을 밝힘으로써 TIM-3 발현 조절 기작을 이해하는데 중요한 초석이 된다.","\"차 례 국문요약 &#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729; i 차례 &#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729; ii 그림 차례 &#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729; iii 표 차례 &#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729; vi I. 서론 &#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729; 1 II. 재료 및 방법 &#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729; 5 A. TIM-3 upstream DNA와 intron 을 삽입한 luciferase reporter plasmid 제작 &#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729; 5 B. 세포배양과 plasmid의 세포이입 &#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729; 6 C. Luciferase reporter assay &#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729; 8 D. RNA 추출과 Real-time PCR &#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729; 8 E. Site directed mutagenesis &#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729; 11 F. 통계처리 &#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729; 11 III. 결과 &#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729; 13 A. TGF-β 자극에 의한 TIM-3 mRNA 발현 증가 &#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729; 13 B. 인간과 생쥐의 TIM-3 regulatory DNA의 상동성 분석 &#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729; 13 C. HMC-1의 TIM-3 regulatory DNA 염기서열 분석 &#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729; 20 D. TIM-3 발현 조절 DNA의 luciferase reporter vector 생산 &#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729; 20 E. Basal level의 TIM-3 전사활성에 중요한 DNA region 분석 &#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729; 25 F. TGF-β 자극에 따른 TIM-3 전사증가에 관여하는 DNA region분석 &#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729; 30 G. Smad 분자 과발현이 TIM-3 enhancer/promoter 활성에 미치는 영향 &#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729; 30 IV. 고찰 &#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729; 33 V. 결론 &#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729; 37 참고문헌 &#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729; 38 ABSTRACT &#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729; 45 그 림 차 례 Fig. 1. HMC-1 세포와 HEK 293 세포의 TGF-β 자극에 의한 TIM-3 mRNA 양의 변화 &#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729; 15 Fig. 2. 사람 TIM-3와 생쥐 tim-3의 upstream DNA와 intron 염기서열의 상동성 분석 &#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729; 17 Fig. 3. 인간 혈액/정자에서 보고된 TIM-3 유전자 염기서열과 HMC-1에서 분리한 TIM-3 upstream DNA의 염기서열 비교 &#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729; 22 Fig. 4. TIM-3의 upstream DNA와 intron 1과 2의 luciferase reporter vector 제작 &#8729;&#8729;&#8729; 23 Fig. 5. TIM-3 조절 유전자에 의한 luciferase 활성 분석 &#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729; 27 Fig. 6. TGF-β 자극이 TIM-3 upstream DNA에 의한 luciferase 활성에 미치는 영향 &#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729; 31 Fig. 7. TIM-3 upstream DNA에 의한 luciferase 활성에 smad 과발현이 미치는 영향 &#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729; 32 표 차 례 Table. 1. Primers for amplification of TIM-3 upstream DNA and introns &#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729; 7 Table. 2. Primers and probes for real-time PCR &#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729; 9 Table 3. Primers for site directed mutagenesis &#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729;&#8729; 12 \"","Master"],"dc:identifier":["http://repository.ajou.ac.kr/handle/201003/2246","http://dcoll.ajou.ac.kr:9080/dcollection/jsp/common/DcLoOrgPer.jsp?sItemId=000000009556","000000009556"],"dc:language":["ko"],"dc:subject":["T cell immunoglobulin- and mucin domain-3(TIM-3)","전사","프로모터"],"dc:title":["Identification of Regulatory DNA Region and Transcription Factors Important for TIM-3 Transcription","TIM-3 발현 조절에 중요한 DNA region과 이에 관여하는 전사인자 분석"],"dc:type":["Thesis","Theses"]},"updated_at":"2026-07-24T00:51:31Z"}